SCHEMBL5244282

SCHEMBL5244282

O=C(NCC(F)(F)F)c1ccc(-n2nnc(C(=O)NCCCCO)c2CCCCCF)cc1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 3/20 0.38
POLB P06746 1/20 0.37
FOLH1 Q04609 4/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TRPV1 Q8NER1 1/20 0.35
PDK2 Q15119 1/20 0.34
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
HTT P42858 1/20 0.34
NAMPT P43490 2/20 0.33
OPRD1 P41143 1/20 0.33
P2RY14 Q15391 1/20 0.33
SIGMAR1 Q99720 1/20 0.33
MKNK1 Q9BUB5 1/20 0.33
MKNK2 Q9HBH9 1/20 0.33
MAPK1 P28482 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5249369 0.97 MLYCD (0.36) MLYCDPOLBFOLH1NPC1RAB9A
SCHEMBL3106801 0.94 HDAC4 (0.35) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
SCHEMBL5245108 0.91 NPC1 (0.37) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
SCHEMBL3112810 0.90 MLYCD (0.36) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL3117680 0.90 MEN1 (0.37) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
SCHEMBL5246507 0.90 ALDH1A1 (0.34) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
SCHEMBL3112218 0.89 RAB9A (0.36) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
SCHEMBL5246279 0.89 RAB9A (0.40) MLYCDFOLH1NPC1RAB9ASMN1; SMN2
SCHEMBL5245660 0.89 MLYCD (0.50) MLYCDPOLBNPC1RAB9ASMN1; SMN2
SCHEMBL3113751 0.88 HPGD (0.41) MLYCDNPC1RAB9ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1867331-A1 TRIAZOLE DERIVATIVE AND THE USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2007-12-19 EP disclosed